trending Market Intelligence /marketintelligence/en/news-insights/trending/h02E6RvMdj4481FOkhh1oA2 content esgSubNav
In This List

UniQure appoints COO, chief scientific officer, nominates board members


Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection


Japan M&A By the Numbers: Q4 2023


Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

UniQure appoints COO, chief scientific officer, nominates board members

Scott McMillan became uniQure NV's COO, joined by Sander van Deventer who was appointed the company's chief scientific officer.

McMillan most recently served as the senior vice president of quality and technical operations at AMAG Pharmaceuticals Inc.

Van Deventer, who was also named the company's general manager for Amsterdam, is a co-founder of uniQure. He will resign from the company's board upon the appointment of his replacement, which is expected to occur Sept. 14.

Meanwhile, Christian Klemt was promoted to the position of chief accounting officer from the global controller of the company.

Further, Madhavan Balachandran and Jeremy Springhorn were nominated as directors of the company and will be added to the board at the company's shareholder meeting on Sept. 14. Will Lewis will be resigning from the board on the same date.

Balachandran is Amgen Inc.'s former executive vice president of operations, while Springhorn is Alexion Pharmaceuticals Inc.'s former vice president of corporate development.